COVID-19: Outpatient Therapeutic Updates
New data have emerged regarding treatment principles and therapeutic options for nonhospitalized adult and pediatric patients with COVID-19. Hear a faculty expert describe treatment options and treatments to avoid.
Decera Clinical Education Infectious Disease Podcast · Sharon R. Lewin AO FRACP PhD FAHMS, Sharon Lewin
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, discusses:
Principles for antiviral agent use in nonhospitalized patients
- Preferred and alternative treatment options
- Treatment prioritization when there are logistical or supply constraints
Outpatient remdesivir use
- PINETREE data (adult patients)
- CARAVAN data (pediatric patients)
- FDA approval and treatment candidacy
Therapeutic updates
- Ivermectin and the TOGETHER study
- Monoclonal antibody use during current omicron era
Presenter:
Sharon R. Lewin, AO, FRACP, PhD, FAHMSZ
Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia
Review the downloadable slideset at:
https://bit.ly/3FXc90w
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.